Pricing Log in Create free account
Saturday 17 October 2026 Export RVTY’s income statement to Excel — free account

Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

152.64 2.07 −1.34%
Market cap
$17.3B
P/E
72.7×
Fwd P/E
37.5×
Dividend yield
0.23%
F-score
6/9
Altman Z
2.49
Beneish M
−2.45
Dividend safety
80/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Revvity Inc. (RVTY) Debt to equity

Alert me on Debt to equity

Revvity Inc.'s debt to equity at the end of the quarter to 30 June 2026 was 0.4×, down 0.0× from fiscal 2025 (0.4×). Over the past ten years it has ranged from 0.4× (fiscal 2024) to 0.8× (fiscal 2017); the current reading is higher than 18% of that period. That is above the Diagnostics & Research industry median of 0.1× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2025 0.4× 8.05%
FY2024 0.4× (17.02%)
FY2023 0.5× (16.78%)
FY2022 0.6× (14.72%)
FY2021 0.7× 30.96%
FY2020 0.5× (27.70%)
FY2019 0.7× 0.74%
FY2018 0.7× (8.70%)
FY2017 0.8× 64.93%
FY2016 0.5× 1.25%

Quarterly newest first

Period Debt to equity Change
Jun 2026 0.4× (0.72%)
Mar 2026 0.4× 0.56%
Dec 2025 0.4× 1.90%
Sep 2025 0.4× 2.44%
42 more quarters

Against its own ten years

Low 0.4× High 0.8×
Ten-year median 0.5×
Current reading's percentile 18

Debt to equity against peers

Company Debt to equity
GH Guardant Health, Inc. compare −6.7×
MEDP Medpace Holdings, Inc. compare 0.0×
TWST Twist Bioscience Corporation compare 0.0×
ICLR ICON PLC compare 0.4×
RVTY Revvity Inc. 0.4×
QGEN QIAGEN N.V. compare 0.5×
LH Labcorp Holdings Inc. compare 0.7×
DGX Quest Diagnostics Incorporated compare 0.7×
CRL Charles River Laboratories International, Inc. compare 0.9×
Diagnostics & Research industry median 0.1×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on RVTY